Cuvrior 300 MG Oral Tablet

RxCUI: 2611550
RxNorm name: Cuvrior 300 MG Oral Tablet
Display name: Cuvrior 300 MG Oral Tablet
Full name: Cuvrior 300 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CUVRIOR	TRIENTINE TETRAHYDROCHLORIDE	Orphalan SA	f73feeae-62ad-401e-b9f7-5cb269127750	2025-06-19	Warnings, Adverse reactions	Exact identifier rxcui: 2611550

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
f73feeae-62ad-401e-b9f7-5cb269127750	Cuvrior 300 MG Oral Tablet	SY	7	These highlights do not include all the information needed to use CUVRIOR safely and effectively. See full prescribing information for CUVRIOR. CUVRIOR ® (trientine tetrahydrochloride) tablets, for oral use Initial U.S. Approval: 1985	20250619
f73feeae-62ad-401e-b9f7-5cb269127750	Cuvrior 300 MG (as trientine 150 MG) Oral Tablet	SY	7	These highlights do not include all the information needed to use CUVRIOR safely and effectively. See full prescribing information for CUVRIOR. CUVRIOR ® (trientine tetrahydrochloride) tablets, for oral use Initial U.S. Approval: 1985	20250619
f73feeae-62ad-401e-b9f7-5cb269127750	Cuvrior 300 MG Oral Tablet	PSN	7	These highlights do not include all the information needed to use CUVRIOR safely and effectively. See full prescribing information for CUVRIOR. CUVRIOR ® (trientine tetrahydrochloride) tablets, for oral use Initial U.S. Approval: 1985	20250619
f73feeae-62ad-401e-b9f7-5cb269127750	trientine tetrahydrochloride 300 MG Oral Tablet [Cuvrior]	SBD	7	These highlights do not include all the information needed to use CUVRIOR safely and effectively. See full prescribing information for CUVRIOR. CUVRIOR ® (trientine tetrahydrochloride) tablets, for oral use Initial U.S. Approval: 1985	20250619